Sixfold Bioscience
Sixfold Bioscience is a startup headquartered in London, United Kingdom, founded in 2017. It has won about £1.64m in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Sixfold Bioscience has won about £1.64m in competitive Innovate UK grants since 2023.
- A Machine Learning-Driven Approach for Optimising RNA Therapeutic Delivery via Generative Modelling (£1.09m, 2025)
- INDUCE: Development of siRNA-Mergo® therapeutics for lung indications. (£257k, 2023)
- Investigation of Mergo? mechanism of action by quantitative serum protein profiling. (£9k, 2023)
- ENHANCE: Scaling up development of novel Mergo® formulations via optimised synthesis and high-throughput strategies (£293k, 2023)
R&D ecosystem
Sixfold Bioscience sits inside the London and the Golden Triangle R&D ecosystem in the Global R&D Labs Directory.
Other startups in London
- Abtrace
- Adjsoft
- Aeon Energy
- Amphibio
- Anserine Labs
- APIContext
- Apoha
- AppyParking
- Archangel Lightworks
- Arda Biomaterials
- Bark
Related
- Innovation profile of London
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Sixfold Bioscience do?
Sixfold Bioscience works in biotechnology. Its Innovate UK projects include: A Machine Learning-Driven Approach for Optimising RNA Therapeutic Delivery via Generative Modelling.
Where is Sixfold Bioscience based?
Sixfold Bioscience is headquartered in London, United Kingdom.
When was Sixfold Bioscience founded?
Sixfold Bioscience was founded in 2017.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.